
Company Info
Phone(206) 237-1030
Year Established
2003
Ticker
ZMME
Exchange
NYSE
Contacts
Kenneth GalbraithChair & CEO
Chris Astle PhD
Senior VP, CFO
Paul Moore PhD
CSO
Daniel Dex JD
General Counsel
Lucas Donigian
Executive Director, Business Development
Company Description
Zymeworks is a clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer.